Articles published by Hyperfine, Inc.
Hyperfine Expands Global Market Reach with New Distribution Partnerships in European and Middle Eastern Markets
December 17, 2024
From Hyperfine, Inc.
Via Business Wire
Tickers
HYPR
Hyperfine Announces Strategic Leadership Additions to Drive Growth in Key Business Verticals
December 03, 2024
From Hyperfine, Inc.
Via Business Wire
Tickers
HYPR
Hyperfine Swoop® Portable MR Brain Imaging System Meets New Standards Recently Issued by CMS-Approved Accrediting Body
November 21, 2024
From Hyperfine, Inc.
Via Business Wire
Tickers
HYPR
Hyperfine, Inc. to Participate in Upcoming Investor Conferences
November 13, 2024
From Hyperfine, Inc.
Via Business Wire
Tickers
HYPR
Hyperfine, Inc. Reports Third Quarter 2024 Financial Results
November 12, 2024
From Hyperfine, Inc.
Via GlobeNewswire
Tickers
HYPR
Hyperfine Announces European Launch with CE Approval
November 07, 2024
From Hyperfine, Inc.
Via Business Wire
Tickers
HYPR
Hyperfine Announces Alzheimer’s Research with Promising Swoop® System Data and Advanced Image Quality
October 31, 2024
From Hyperfine, Inc.
Via Business Wire
Tickers
HYPR
Hyperfine, Inc. to Announce Third Quarter 2024 Financial Results on November 12, 2024
October 24, 2024
From Hyperfine, Inc.
Via Business Wire
Tickers
HYPR
Hyperfine Announces Promising Interim Findings on the Value of Portable, Ultra-low-field MR Imaging for Acute Stroke Care
September 23, 2024
From Hyperfine, Inc.
Via Business Wire
Tickers
HYPR
Hyperfine, Inc. to Participate in Upcoming Investor Conferences
August 28, 2024
From Hyperfine, Inc.
Via Business Wire
Tickers
HYPR
Hyperfine, Inc. Reports Record Quarterly Revenue and Raises FY 2024 Revenue Guidance
August 08, 2024
From Hyperfine, Inc.
Via GlobeNewswire
Tickers
HYPR
Hyperfine Expands European Market Reach with Additional Strategic Distributor Partners
July 10, 2024
From Hyperfine, Inc.
Via Business Wire
Tickers
HYPR
Hyperfine, Inc. Celebrates ASNR 2024
May 22, 2024
From Hyperfine, Inc.
Via Business Wire
Tickers
HYPR
Leading Institutions Enroll First Alzheimer’s Patients Receiving Amyloid-Targeting Therapy in CARE PMR Study
April 17, 2024
From Hyperfine, Inc.
Via Business Wire
Tickers
HYPR
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.